Predictors of outcomes with covalent BTK inhibitor treatment in relapsed/refractory TP53-mutant mantle cell lymphoma

Uppal M, Joseph A, Drill E, Hamlin P, Falchi L, Noy A, Owens C, Epstein-Peterson ZD, Salles G, Zelenetz AD, Kumar A
У данной статьи нет абстракта.
British journal of haematology, 2025-06-25